Outlook for 2026

ABX has enough funds to confirm viability of its REE project which is continuing to grow and has high levels of the most in-demand and valuable REEs.

ABX has three legs to its enterprise: Bauxite in Tasmania, Queensland and NSW is one; but the most promising are
the ALCORE venture based on groundbreaking metallurgical process to recover aluminium fluorite that has global application in the production of aluminium and the third is its already spectacular rare earth resource. The rare earths are in great demand now that the free developed world are waking up that they need supply chains independent of the autocracies - particularly China and Russia.


So there is heaps of upside this year for ABX with bauxite, ALCORE & REE.

ABX know REE are associated with their northern Tassie bauxite deposits so there is synergy with any exploration work already done. The have only drilled about a third of the prospective resource area on the older exploration tenements to the west of Launceston & are just starting on the much larger tenements to the SE, hence the very early but encouraged results recently announced. Then there are the brand-new tenements to the north around Beaconsfield which haven't been touched yet.

Things that I like about the REE deposits that ABX is finding and delineating in northern Tas are that they are very close to the surface, in ionic adsobrtion clays, close to a port and an industrial area which all spells low cost. They contain high concentrations of the highest value and most in demand rare earth oxides and have been shown to be relatively straight forward to extract and purify requiring only low concentrations of chemicals which spells high value and revenues and also low cost. They are still finding more but Mark has also spelled out this will mean that it is likely to be economic to start production early at small scale initially which means less capital. Strategic minerals in high demand also increases the likelihood of more grants.

Plenty of good news flow to come I expect.